Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07746427

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Conditions: Atopic Dermatitis, Eczema

Sex: All
Ages: 13 Years – 17 Years
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: Weill Medical College of Cornell University

Location: Weill Cornell Medicine New York New York

Summary

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Eligibility Criteria

Inclusion Criteria * Adolescents age 13-17 years. * Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors. * Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment. Exclusion Criteria * Started on a biologic agent (i.e. dupxient) within the past 3 months. * Mild atopic dermatitis via PO-SCORAD score on enrollment.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07746427). StuddyBuddy aggregates publicly available trial information.